BIAF — BioAffinity Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- $8.18m
- $8.11m
- $9.36m
Annual cashflow statement for BioAffinity Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.27 | -6.33 | -8.15 | -7.94 | -9.04 |
| Depreciation | |||||
| Non-Cash Items | 4.56 | 3.64 | 3.96 | 0.749 | 0.99 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.483 | 0.633 | 0.114 | 0.901 | 0.18 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -2.21 | -2.05 | -4.07 | -6.04 | -7.26 |
| Capital Expenditures | -0.003 | 0 | -0.22 | -0.023 | -0.079 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -2.19 | 0 |
| Acquisition of Business | |||||
| Cash from Investing Activities | -0.003 | 0 | -0.22 | -2.21 | -0.079 |
| Financing Cash Flow Items | 0 | -0.181 | -0.056 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.72 | 3.33 | 14.3 | -0.345 | 5.63 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.495 | 1.28 | 10.1 | -8.59 | -1.72 |